Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study

Lancet Neurology

Volumn 6, Issue 12, 2007, Pages 1106-1114

  Seshadri, Sudha ^a   Wolf, Philip A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ALZHEIMER DISEASE; ARTICLE; BREAST CANCER; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DATA ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HIP FRACTURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; LIFESPAN; LUNG CANCER; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARKINSON DISEASE; PARKINSONISM; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; SEX DIFFERENCE; STROKE; UNITED STATES;

EID: 36249023276     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70291-0     Document Type: Note

References (60)

1. World Health Organization. Major burden of disease-leading 10 selected risk factors and leading 10 diseases and injuries in developed countries with low mortality levels. The World Health Report 2002 Statistical Annex, Annex 16 June 2007; Available at: http://www.who.int/whr/2002/annex/en/ (accessed January 12, 2006).
2. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
3. Seshadri S., Drachman D., and Lippa C. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know. Arch Neurol 52 (1995) 1074-1079
4. Cashman R., Gerhardt P., Goldberg I., Handy V., and Levin M. The probability of developing cancer. J Natl Cancer Inst 17 (1956) 155-173
5. Feuer E., Wun L., Boring C., Flanders W., Timmel M., and Tong T. The lifetime risk of developing breast cancer. J Natl Cancer Inst 85 (1993) 892-897
6. Bender A., Punyko J., Williams A., and Bushhouse S. A standard person-years approach to estimating lifetime cancer risk. The Section of Chronic Disease and Environmental Epidemiology, Minnesota Department of Health. Cancer Causes Control 3 (1992) 69-75
7. Suman V., Atkinson E., O'Fallon W., Black D., and Melton III L. A nomogram for predicting lifetime hip fracture risk from radius bone mineral density and age. Bone 14 (1993) 843-846
8. Kramer M., von K., and Kessler L. The lifetime prevalence of mental disorders: estimation, uses and limitations. Psychol Med 10 (1980) 429-435
9. Seshadri S., Wolf P., Beiser A., et al. Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. Neurology 49 (1997) 1498-1504
10. Melton III L. Lifetime risk of a hip fracture. Am J Public Health 80 (1990) 500-501
11. Seshadri S., Beiser A., Kelly-Hayes M., et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 37 (2006) 345-350
12. Vasan R., Beiser A., Seshadri S., et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA 287 (2002) 1003-1010
13. Vasan R., Pencina M., Cobain M., Freiberg M., and D'Agostino R. Estimated risks for developing obesity in the Framingham Heart Study. Ann Intern Med 143 (2005) 473-480
14. Bryant H. Breast cancer in Canadian women. BMC Women's Health 4 suppl 1 (2004) S12
15. Corder E., Saunders A., Strittmatter W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
16. Drachman D. If we live long enough, will we all be demented?. Neurology 44 (1994) 1563-1565
17. Schouten L., Straatman H., Kiemeney L., and Verbeek A. Cancer incidence: life table risk versus cumulative risk. J Epidemiol Community Health 48 (1994) 596-600
18. Breitner J. Clinical genetics and genetic counseling in Alzheimer's disease. Ann Intern Med 115 (1991) 601-606
19. Sayetta R. Rates of senile dementia, Alzheimer's type, in the Baltimore Longitudinal Study. J Chronic Dis 39 (1986) 271-286
20. Beiser A., D'Agostino Sr. R., Seshadri S., Sullivan L., and Wolf P. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med 19 (2000) 1495-1522
21. Dawber T., Meadors G., and Moore Jr. F. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 41 (1951) 279-281
22. Kannel W., Dawber T., and McNamara P. Vascular disease of the brain - epidemiologic aspects: the Framingham Study. Am J Public Health 55 (1965) 1355-1366
23. Wolf P., Dawber T., Thomas H., Colton T., and Kannel W. Epidemiology of stroke. In: Thompson R., and Green J. (Eds). Advances in neurology: stroke (1977), Raven Press, New York 5-19
24. Hollander M., Koudstaal P., Bots M., Grobbee D., Hofman A., and Breteler M. Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry 74 (2003) 317-321
25. Leary M., and Saver J. Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis 16 (2003) 280-285
26. Guccione A., Felson D., Anderson J., et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health 84 (1994) 351-358
27. Kelly-Hayes M., Wolf P., Kannel W., Sytkowski P., D'Agostino R., and Gresham G. Factors influencing survival and need for institutionalization following stroke: the Framingham Study. Arch Phys Med Rehabil 69 (1988) 415-418
28. Ott A., Breteler M., van H., Stijnen T., and Hofman A. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 147 (1998) 574-580
29. Wolf P., Kannel W., and Verter J. Current status of risk factors for stroke. Neurol Clin 1 (1983) 317-343
30. Wolf P., D'Agostino R., Belanger A., and Kannel W. Probability of stroke: a risk profile from the Framingham Study. Stroke 22 (1991) 312-318
31. Carandang R., Seshadri S., Beiser A., et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 296 (2006) 2939-2946
32. Mamun A., Peeters A., Barendregt J., Willekens F., Nusselder W., and Bonneux L. Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study. Eur Heart J 25 (2004) 409-415
33. Lloyd-Jones D., Larson M., Beiser A., and Levy D. Lifetime risk of developing coronary heart disease. Lancet 353 (1999) 89-92
34. Lloyd-Jones D. The risk of congestive heart failure: sobering lessons from the Framingham Heart Study. Curr Cardiol Rep 3 (2001) 184-190
35. Lloyd-Jones D., Wang T., Leip E., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110 (2004) 1042-1046
36. Merrill R., Kessler L., Udler J., Rasband G., and Feuer E. Comparison of risk estimates for selected diseases and causes of death. Prev Med 28 (1999) 179-193
37. Merrill R., and Weed D. Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates. Ann Epidemiol 11 (2001) 547-553
38. Fuller R., Dudley N., and Blacktop J. Older people's understanding of cumulative risks when provided with annual stroke risk information. Postgrad Med J 80 (2004) 677-678
39. Segal M. Breast cancer complacency: he enemy of cure. http://www.fda.gov/bbs/topics/CONSUMER/CON00097.html (accessed September 22, 2007).
40. Eckert S., Katzen H., Roberts J., et al. Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL Study. Genet Med 8 (2006) 746-751
41. Chobanian A., Bakris G., Black H., et al. the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
42. Suman V., Atkinson E., O'Fallon W., Black D., and Melton III L. A nomogram for predicting lifetime hip fracture risk from radius bone mineral density and age. Bone 14 (1993) 843-846
43. Lloyd-Jones D., Leip E., Larson M., et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 113 (2006) 791-798
44. Mosca L., Banka C., Benjamin E., et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 115 (2007) 1481-1501
45. Pickle L., Mungiole M., and Gillum R. Geographic variation in stroke mortality in blacks and whites in the United States. Stroke 28 (1997) 1639-1647
46. Tolonen H., Mahonen M., Asplund K., et al. Do trends in population levels of blood pressure and other cardiovascular risk factors explain trends in stroke event rates? Comparisons of 15 populations in 9 countries within the WHO MONICA Stroke Project. World Health Organization monitoring of trends and determinants in cardiovascular disease. Stroke 33 (2002 October) 2367-2375
47. Regional and racial differences in prevalence of stroke-23 states and District of Columbia, 2003. MMWR Morb Mortal Wkly Rep 54 (2005) 481-484
48. Kanis J., Johnell O., De Laet C., Jonsson B., Oden A., and Ogelsby A. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17 (2002) 1237-1244
49. Dyall L., Carter K., Bonita R., et al. Incidence of stroke in women in Auckland, New Zealand. Ethnic trends over two decades: 1981-2003. N Z Med J 119 (2006) U2309
50. Carter K., Anderson C., Hacket M., et al. Trends in ethnic disparities in stroke incidence in auckland, new zealand, during 1981 to 2003. Stroke 37 (2006) 56-62
51. Pencina M., D'Agostino R., Beiser A., Cobain M., and Vasan R. Estimating lifetime risk of developing high serum total cholesterol: adjustment for baseline prevalence and single-occasion measurements. Am J Epidemiol 165 (2007) 464-472
52. Narayan K., Boyle J., Thompson T., Sorensen S., and Williamson D. Lifetime risk for diabetes mellitus in the United States. JAMA 290 (2003) 1884-1890
53. Narayan K., Boyle J., Thompson T., Gregg E., and Williamson D. Effect of BMI on lifetime risk for diabetes in the USA. Diabetes Care 30 (2007) 1562-1566
54. Seshadri S., Beiser A., Kelly-Hayes M., Kase C., Kannel W., and Wolf P. Is declining stroke incidence due to changes in risk factor prevalence or impact? Recalibrating the Framingham stroke risk profile to reflect temporal trends. Stroke 388 (2007) 481 (abstr).
55. Elbaz A., Bower J., Maraganore D., et al. Risk tables for parkinsonism and Parkinson's disease. J Clin Epidemiol 55 (2002) 25-31
56. Singh R., Gamble G., and Cundy T. Lifetime risk of symptomatic carpal tunnel syndrome in type 1 diabetes. Diabet Med 22 (2005) 625-630
57. Lloyd-Jones D., Larson M., Leip E., et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106 (2002) 3068-3072
58. Stat bite: lifetime risk of being diagnosed with cancer. J Natl Cancer Inst 95 (2003) 1745
59. Merrill R., Weed D., and Feuer E. The lifetime risk of developing prostate cancer in white and black men. Cancer Epidemiol Biomarkers Prev 6 (1997) 763-768
60. Lloyd-Jones D., Dyer A., Wang R., Daviglus M., and Greenland P. Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry). Am J Cardiol 99 (2007) 535-540